遺伝子組換えヒト副甲状腺ホルモンの世界市場インサイト、2029年までの予測Global Recombinant Human Parathyroid Hormone Market Insights, Forecast to 2029 遺伝子組換えヒト副甲状腺ホルモンの世界市場は、2023年の100万米ドルから2029年には100万米ドルに達し、予測期間中の年間平均成長率(CAGR)は%になると予測されています。 遺伝子組換えヒト副甲状腺ホルモンの... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー遺伝子組換えヒト副甲状腺ホルモンの世界市場は、2023年の100万米ドルから2029年には100万米ドルに達し、予測期間中の年間平均成長率(CAGR)は%になると予測されています。遺伝子組換えヒト副甲状腺ホルモンの米国・カナダ市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中にCAGR %で増加すると予測されます。 遺伝子組換えヒト副甲状腺ホルモンの中国市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中にCAGR %で増加すると考えられています。 遺伝子組換えヒト副甲状腺ホルモンのヨーロッパ市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年までの予測期間中にCAGR %で増加すると考えられています。 遺伝子組換えヒト副甲状腺ホルモンの世界の主要メーカーは、NPS Pharma(Shire)、武田薬品、Shandong Buchang Pharmaceuticals、Ascendis Pharma、Beijing SL Pharmaceuticalなどです。2022年、世界の上位5社は売上高で約 %のシェアを占めています。 レポートには、以下の内容が含まれています: 本レポートでは、遺伝子組換えヒト副甲状腺ホルモンの世界市場の概要、売上、収益、価格などを紹介しています。2018年~2022年の過去の市場収益/売上データ、2023年の予測、2029年までのCAGRの予測など、世界市場動向の分析が可能。 本レポートでは、組換えヒト副甲状腺ホルモンの主要生産者を調査し、主要地域や国の売上も掲載しています。遺伝子組換え型ヒト副甲状腺ホルモンの今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国の注目点。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他諸国の国別データおよび市場価値分析。 本レポートでは、2018年から2023年のデータをもとに、組み換えヒト副甲状腺ホルモンの売上、収益、主要メーカーの市場シェア、業界ランキングに焦点を当てます。組み換えヒト副甲状腺ホルモンの世界市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づき分析します。本レポートは、関係者が競争環境を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立つことでしょう。 本レポートでは、2018年から2029年までの、タイプ別、用途別のセグメントデータ、売上、収益、価格を分析しています。遺伝子組換えヒト副甲状腺ホルモンの売上、予測される成長動向、生産技術、用途、エンドユーザー産業の評価と市場規模を予測します。 NPS Pharma(Shire)、武田薬品、Shandong Buchang Pharmaceuticals、Ascendis Pharma、Beijing SL Pharmaceuticalなど、世界の主要プレイヤーの詳細な会社プロファイル。 会社別 NPSファーマ(シャイアー) 武田 山東佛光医薬有限公司(Shandong Buchang Pharmaceuticals アセンジス・ファーマ 北京SL製薬 タイプ別セグメント 25mcg/回 50mcg/回 75mcg/回 100mcg/回 用途別セグメント 骨粗鬆症の閉経後女性 副甲状腺機能低下症患者における低カルシウム血症について 地域別セグメント アメリカ・カナダ U.S. カナダ 中国 アジア(中国を除く) 日本 南朝鮮 中国 台湾 東南アジア インド ヨーロッパ ドイツ フランス イギリス イタリア ロシア 中近東、アフリカ、中南米 ブラジル メキシコ トルコ イスラエル GCC諸国 章立て 第1章:報告書のスコープ、市場セグメント別(タイプ別、用途別など)のエグゼクティブサマリー、各市場セグメントの市場規模、将来の発展可能性などを紹介。市場の現状と、短中期および長期的にどのような進化を遂げる可能性があるのかについて、ハイレベルな視点で解説しています。 第2章:遺伝子組換えヒト副甲状腺ホルモンの世界、地域レベル、国レベルでの販売(消費)、収益。各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来の発展見通し、市場スペース、生産能力などを紹介しています。 第3章:遺伝子組換えヒト副甲状腺ホルモンメーカーの競争環境、価格、売上、収益、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析します。 第4章:各種市場セグメントを種類別に分析し、各市場セグメントの売上高、収益、平均価格、発展可能性を網羅し、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。 第5章:読者が異なる下流市場でブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーする、様々な市場セグメントのアプリケーションの分析を提供します。 第6章:米国とカナダ(US & Canada)タイプ別、アプリケーション別、国別、各セグメント別の売上と収益。 第7章:ヨーロッパ(Europe):タイプ別、アプリケーション別、国別、セグメント別の売上高と収益。 第8章:中国 種類別、用途別、国別、各セグメント別の売上と収益。 第9章:アジア(中国を除く) タイプ別、アプリケーション別、地域別、各セグメント別の売上と収益。 第10章:中東、アフリカ、中南米:タイプ別、アプリケーション別、国別、各セグメント別の売上高と収益。 第11章:主要メーカーのプロファイルを提供し、製品の説明や仕様、組み換えヒト副甲状腺ホルモンの売上、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本状況を詳細に紹介する。 第12章:産業チェーン、販売チャネル、主要原材料、流通業者、顧客に関する分析。 第13章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析などを紹介します。 第14章:本レポートの要点と結論。 目次1 Study Coverage1.1 Recombinant Human Parathyroid Hormone Product Introduction 1.2 Market by Type 1.2.1 Global Recombinant Human Parathyroid Hormone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 25 mcg/dose 1.2.3 50 mcg/dose 1.2.4 75 mcg/dose 1.2.5 100 mcg/dose 1.3 Market by Application 1.3.1 Global Recombinant Human Parathyroid Hormone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Postmenopausal Women with Osteoporosis 1.3.3 Hypocalcemia in Patients with Hypoparathyroidism 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Recombinant Human Parathyroid Hormone Sales Estimates and Forecasts 2018-2029 2.2 Global Recombinant Human Parathyroid Hormone Revenue by Region 2.2.1 Global Recombinant Human Parathyroid Hormone Revenue by Region: 2018 VS 2022 VS 2029 2.2.2 Global Recombinant Human Parathyroid Hormone Revenue by Region (2018-2023) 2.2.3 Global Recombinant Human Parathyroid Hormone Revenue by Region (2024-2029) 2.2.4 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Region (2018-2029) 2.3 Global Recombinant Human Parathyroid Hormone Sales Estimates and Forecasts 2018-2029 2.4 Global Recombinant Human Parathyroid Hormone Sales by Region 2.4.1 Global Recombinant Human Parathyroid Hormone Sales by Region: 2018 VS 2022 VS 2029 2.4.2 Global Recombinant Human Parathyroid Hormone Sales by Region (2018-2023) 2.4.3 Global Recombinant Human Parathyroid Hormone Sales by Region (2024-2029) 2.4.4 Global Recombinant Human Parathyroid Hormone Sales Market Share by Region (2018-2029) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufactures 3.1 Global Recombinant Human Parathyroid Hormone Sales by Manufacturers 3.1.1 Global Recombinant Human Parathyroid Hormone Sales by Manufacturers (2018-2023) 3.1.2 Global Recombinant Human Parathyroid Hormone Sales Market Share by Manufacturers (2018-2023) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Parathyroid Hormone in 2022 3.2 Global Recombinant Human Parathyroid Hormone Revenue by Manufacturers 3.2.1 Global Recombinant Human Parathyroid Hormone Revenue by Manufacturers (2018-2023) 3.2.2 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Manufacturers (2018-2023) 3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Parathyroid Hormone Revenue in 2022 3.3 Global Key Players of Recombinant Human Parathyroid Hormone, Industry Ranking, 2021 VS 2022 VS 2023 3.4 Global Recombinant Human Parathyroid Hormone Sales Price by Manufacturers 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global Recombinant Human Parathyroid Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of Recombinant Human Parathyroid Hormone, Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of Recombinant Human Parathyroid Hormone, Product Offered and Application 3.8 Global Key Manufacturers of Recombinant Human Parathyroid Hormone, Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Recombinant Human Parathyroid Hormone Sales by Type 4.1.1 Global Recombinant Human Parathyroid Hormone Historical Sales by Type (2018-2023) 4.1.2 Global Recombinant Human Parathyroid Hormone Forecasted Sales by Type (2024-2029) 4.1.3 Global Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2029) 4.2 Global Recombinant Human Parathyroid Hormone Revenue by Type 4.2.1 Global Recombinant Human Parathyroid Hormone Historical Revenue by Type (2018-2023) 4.2.2 Global Recombinant Human Parathyroid Hormone Forecasted Revenue by Type (2024-2029) 4.2.3 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Type (2018-2029) 4.3 Global Recombinant Human Parathyroid Hormone Price by Type 4.3.1 Global Recombinant Human Parathyroid Hormone Price by Type (2018-2023) 4.3.2 Global Recombinant Human Parathyroid Hormone Price Forecast by Type (2024-2029) 5 Market Size by Application 5.1 Global Recombinant Human Parathyroid Hormone Sales by Application 5.1.1 Global Recombinant Human Parathyroid Hormone Historical Sales by Application (2018-2023) 5.1.2 Global Recombinant Human Parathyroid Hormone Forecasted Sales by Application (2024-2029) 5.1.3 Global Recombinant Human Parathyroid Hormone Sales Market Share by Application (2018-2029) 5.2 Global Recombinant Human Parathyroid Hormone Revenue by Application 5.2.1 Global Recombinant Human Parathyroid Hormone Historical Revenue by Application (2018-2023) 5.2.2 Global Recombinant Human Parathyroid Hormone Forecasted Revenue by Application (2024-2029) 5.2.3 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Application (2018-2029) 5.3 Global Recombinant Human Parathyroid Hormone Price by Application 5.3.1 Global Recombinant Human Parathyroid Hormone Price by Application (2018-2023) 5.3.2 Global Recombinant Human Parathyroid Hormone Price Forecast by Application (2024-2029) 6 US & Canada 6.1 US & Canada Recombinant Human Parathyroid Hormone Market Size by Type 6.1.1 US & Canada Recombinant Human Parathyroid Hormone Sales by Type (2018-2029) 6.1.2 US & Canada Recombinant Human Parathyroid Hormone Revenue by Type (2018-2029) 6.2 US & Canada Recombinant Human Parathyroid Hormone Market Size by Application 6.2.1 US & Canada Recombinant Human Parathyroid Hormone Sales by Application (2018-2029) 6.2.2 US & Canada Recombinant Human Parathyroid Hormone Revenue by Application (2018-2029) 6.3 US & Canada Recombinant Human Parathyroid Hormone Market Size by Country 6.3.1 US & Canada Recombinant Human Parathyroid Hormone Revenue by Country: 2018 VS 2022 VS 2029 6.3.2 US & Canada Recombinant Human Parathyroid Hormone Sales by Country (2018-2029) 6.3.3 US & Canada Recombinant Human Parathyroid Hormone Revenue by Country (2018-2029) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe Recombinant Human Parathyroid Hormone Market Size by Type 7.1.1 Europe Recombinant Human Parathyroid Hormone Sales by Type (2018-2029) 7.1.2 Europe Recombinant Human Parathyroid Hormone Revenue by Type (2018-2029) 7.2 Europe Recombinant Human Parathyroid Hormone Market Size by Application 7.2.1 Europe Recombinant Human Parathyroid Hormone Sales by Application (2018-2029) 7.2.2 Europe Recombinant Human Parathyroid Hormone Revenue by Application (2018-2029) 7.3 Europe Recombinant Human Parathyroid Hormone Market Size by Country 7.3.1 Europe Recombinant Human Parathyroid Hormone Revenue by Country: 2018 VS 2022 VS 2029 7.3.2 Europe Recombinant Human Parathyroid Hormone Sales by Country (2018-2029) 7.3.3 Europe Recombinant Human Parathyroid Hormone Revenue by Country (2018-2029) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China Recombinant Human Parathyroid Hormone Market Size 8.1.1 China Recombinant Human Parathyroid Hormone Sales (2018-2029) 8.1.2 China Recombinant Human Parathyroid Hormone Revenue (2018-2029) 8.2 China Recombinant Human Parathyroid Hormone Market Size by Application 8.2.1 China Recombinant Human Parathyroid Hormone Sales by Application (2018-2029) 8.2.2 China Recombinant Human Parathyroid Hormone Revenue by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Recombinant Human Parathyroid Hormone Market Size by Type 9.1.1 Asia Recombinant Human Parathyroid Hormone Sales by Type (2018-2029) 9.1.2 Asia Recombinant Human Parathyroid Hormone Revenue by Type (2018-2029) 9.2 Asia Recombinant Human Parathyroid Hormone Market Size by Application 9.2.1 Asia Recombinant Human Parathyroid Hormone Sales by Application (2018-2029) 9.2.2 Asia Recombinant Human Parathyroid Hormone Revenue by Application (2018-2029) 9.3 Asia Recombinant Human Parathyroid Hormone Sales by Region 9.3.1 Asia Recombinant Human Parathyroid Hormone Revenue by Region: 2018 VS 2022 VS 2029 9.3.2 Asia Recombinant Human Parathyroid Hormone Revenue by Region (2018-2029) 9.3.3 Asia Recombinant Human Parathyroid Hormone Sales by Region (2018-2029) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Market Size by Type 10.1.1 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Sales by Type (2018-2029) 10.1.2 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Revenue by Type (2018-2029) 10.2 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Market Size by Application 10.2.1 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Sales by Application (2018-2029) 10.2.2 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Revenue by Application (2018-2029) 10.3 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Sales by Country 10.3.1 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Revenue by Country: 2018 VS 2022 VS 2029 10.3.2 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Revenue by Country (2018-2029) 10.3.3 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Sales by Country (2018-2029) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Company Profiles 11.1 NPS Pharma(Shire) 11.1.1 NPS Pharma(Shire) Company Information 11.1.2 NPS Pharma(Shire) Overview 11.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales, Price, Revenue and Gross Margin (2018-2023) 11.1.4 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 NPS Pharma(Shire) Recent Developments 11.2 Takeda 11.2.1 Takeda Company Information 11.2.2 Takeda Overview 11.2.3 Takeda Recombinant Human Parathyroid Hormone Sales, Price, Revenue and Gross Margin (2018-2023) 11.2.4 Takeda Recombinant Human Parathyroid Hormone Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Takeda Recent Developments 11.3 Shandong Buchang Pharmaceuticals 11.3.1 Shandong Buchang Pharmaceuticals Company Information 11.3.2 Shandong Buchang Pharmaceuticals Overview 11.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales, Price, Revenue and Gross Margin (2018-2023) 11.3.4 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Shandong Buchang Pharmaceuticals Recent Developments 11.4 Ascendis Pharma 11.4.1 Ascendis Pharma Company Information 11.4.2 Ascendis Pharma Overview 11.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Sales, Price, Revenue and Gross Margin (2018-2023) 11.4.4 Ascendis Pharma Recombinant Human Parathyroid Hormone Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Ascendis Pharma Recent Developments 11.5 Beijing SL Pharmaceutical 11.5.1 Beijing SL Pharmaceutical Company Information 11.5.2 Beijing SL Pharmaceutical Overview 11.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales, Price, Revenue and Gross Margin (2018-2023) 11.5.4 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Beijing SL Pharmaceutical Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Recombinant Human Parathyroid Hormone Industry Chain Analysis 12.2 Recombinant Human Parathyroid Hormone Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Recombinant Human Parathyroid Hormone Production Mode & Process 12.4 Recombinant Human Parathyroid Hormone Sales and Marketing 12.4.1 Recombinant Human Parathyroid Hormone Sales Channels 12.4.2 Recombinant Human Parathyroid Hormone Distributors 12.5 Recombinant Human Parathyroid Hormone Customers 13 Market Dynamics 13.1 Recombinant Human Parathyroid Hormone Industry Trends 13.2 Recombinant Human Parathyroid Hormone Market Drivers 13.3 Recombinant Human Parathyroid Hormone Market Challenges 13.4 Recombinant Human Parathyroid Hormone Market Restraints 14 Key Findings in The Global Recombinant Human Parathyroid Hormone Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
SummaryThe global Recombinant Human Parathyroid Hormone market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Table of Contents1 Study Coverage1.1 Recombinant Human Parathyroid Hormone Product Introduction 1.2 Market by Type 1.2.1 Global Recombinant Human Parathyroid Hormone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 25 mcg/dose 1.2.3 50 mcg/dose 1.2.4 75 mcg/dose 1.2.5 100 mcg/dose 1.3 Market by Application 1.3.1 Global Recombinant Human Parathyroid Hormone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Postmenopausal Women with Osteoporosis 1.3.3 Hypocalcemia in Patients with Hypoparathyroidism 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Recombinant Human Parathyroid Hormone Sales Estimates and Forecasts 2018-2029 2.2 Global Recombinant Human Parathyroid Hormone Revenue by Region 2.2.1 Global Recombinant Human Parathyroid Hormone Revenue by Region: 2018 VS 2022 VS 2029 2.2.2 Global Recombinant Human Parathyroid Hormone Revenue by Region (2018-2023) 2.2.3 Global Recombinant Human Parathyroid Hormone Revenue by Region (2024-2029) 2.2.4 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Region (2018-2029) 2.3 Global Recombinant Human Parathyroid Hormone Sales Estimates and Forecasts 2018-2029 2.4 Global Recombinant Human Parathyroid Hormone Sales by Region 2.4.1 Global Recombinant Human Parathyroid Hormone Sales by Region: 2018 VS 2022 VS 2029 2.4.2 Global Recombinant Human Parathyroid Hormone Sales by Region (2018-2023) 2.4.3 Global Recombinant Human Parathyroid Hormone Sales by Region (2024-2029) 2.4.4 Global Recombinant Human Parathyroid Hormone Sales Market Share by Region (2018-2029) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufactures 3.1 Global Recombinant Human Parathyroid Hormone Sales by Manufacturers 3.1.1 Global Recombinant Human Parathyroid Hormone Sales by Manufacturers (2018-2023) 3.1.2 Global Recombinant Human Parathyroid Hormone Sales Market Share by Manufacturers (2018-2023) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Parathyroid Hormone in 2022 3.2 Global Recombinant Human Parathyroid Hormone Revenue by Manufacturers 3.2.1 Global Recombinant Human Parathyroid Hormone Revenue by Manufacturers (2018-2023) 3.2.2 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Manufacturers (2018-2023) 3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Parathyroid Hormone Revenue in 2022 3.3 Global Key Players of Recombinant Human Parathyroid Hormone, Industry Ranking, 2021 VS 2022 VS 2023 3.4 Global Recombinant Human Parathyroid Hormone Sales Price by Manufacturers 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global Recombinant Human Parathyroid Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of Recombinant Human Parathyroid Hormone, Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of Recombinant Human Parathyroid Hormone, Product Offered and Application 3.8 Global Key Manufacturers of Recombinant Human Parathyroid Hormone, Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Recombinant Human Parathyroid Hormone Sales by Type 4.1.1 Global Recombinant Human Parathyroid Hormone Historical Sales by Type (2018-2023) 4.1.2 Global Recombinant Human Parathyroid Hormone Forecasted Sales by Type (2024-2029) 4.1.3 Global Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2029) 4.2 Global Recombinant Human Parathyroid Hormone Revenue by Type 4.2.1 Global Recombinant Human Parathyroid Hormone Historical Revenue by Type (2018-2023) 4.2.2 Global Recombinant Human Parathyroid Hormone Forecasted Revenue by Type (2024-2029) 4.2.3 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Type (2018-2029) 4.3 Global Recombinant Human Parathyroid Hormone Price by Type 4.3.1 Global Recombinant Human Parathyroid Hormone Price by Type (2018-2023) 4.3.2 Global Recombinant Human Parathyroid Hormone Price Forecast by Type (2024-2029) 5 Market Size by Application 5.1 Global Recombinant Human Parathyroid Hormone Sales by Application 5.1.1 Global Recombinant Human Parathyroid Hormone Historical Sales by Application (2018-2023) 5.1.2 Global Recombinant Human Parathyroid Hormone Forecasted Sales by Application (2024-2029) 5.1.3 Global Recombinant Human Parathyroid Hormone Sales Market Share by Application (2018-2029) 5.2 Global Recombinant Human Parathyroid Hormone Revenue by Application 5.2.1 Global Recombinant Human Parathyroid Hormone Historical Revenue by Application (2018-2023) 5.2.2 Global Recombinant Human Parathyroid Hormone Forecasted Revenue by Application (2024-2029) 5.2.3 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Application (2018-2029) 5.3 Global Recombinant Human Parathyroid Hormone Price by Application 5.3.1 Global Recombinant Human Parathyroid Hormone Price by Application (2018-2023) 5.3.2 Global Recombinant Human Parathyroid Hormone Price Forecast by Application (2024-2029) 6 US & Canada 6.1 US & Canada Recombinant Human Parathyroid Hormone Market Size by Type 6.1.1 US & Canada Recombinant Human Parathyroid Hormone Sales by Type (2018-2029) 6.1.2 US & Canada Recombinant Human Parathyroid Hormone Revenue by Type (2018-2029) 6.2 US & Canada Recombinant Human Parathyroid Hormone Market Size by Application 6.2.1 US & Canada Recombinant Human Parathyroid Hormone Sales by Application (2018-2029) 6.2.2 US & Canada Recombinant Human Parathyroid Hormone Revenue by Application (2018-2029) 6.3 US & Canada Recombinant Human Parathyroid Hormone Market Size by Country 6.3.1 US & Canada Recombinant Human Parathyroid Hormone Revenue by Country: 2018 VS 2022 VS 2029 6.3.2 US & Canada Recombinant Human Parathyroid Hormone Sales by Country (2018-2029) 6.3.3 US & Canada Recombinant Human Parathyroid Hormone Revenue by Country (2018-2029) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe Recombinant Human Parathyroid Hormone Market Size by Type 7.1.1 Europe Recombinant Human Parathyroid Hormone Sales by Type (2018-2029) 7.1.2 Europe Recombinant Human Parathyroid Hormone Revenue by Type (2018-2029) 7.2 Europe Recombinant Human Parathyroid Hormone Market Size by Application 7.2.1 Europe Recombinant Human Parathyroid Hormone Sales by Application (2018-2029) 7.2.2 Europe Recombinant Human Parathyroid Hormone Revenue by Application (2018-2029) 7.3 Europe Recombinant Human Parathyroid Hormone Market Size by Country 7.3.1 Europe Recombinant Human Parathyroid Hormone Revenue by Country: 2018 VS 2022 VS 2029 7.3.2 Europe Recombinant Human Parathyroid Hormone Sales by Country (2018-2029) 7.3.3 Europe Recombinant Human Parathyroid Hormone Revenue by Country (2018-2029) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China Recombinant Human Parathyroid Hormone Market Size 8.1.1 China Recombinant Human Parathyroid Hormone Sales (2018-2029) 8.1.2 China Recombinant Human Parathyroid Hormone Revenue (2018-2029) 8.2 China Recombinant Human Parathyroid Hormone Market Size by Application 8.2.1 China Recombinant Human Parathyroid Hormone Sales by Application (2018-2029) 8.2.2 China Recombinant Human Parathyroid Hormone Revenue by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Recombinant Human Parathyroid Hormone Market Size by Type 9.1.1 Asia Recombinant Human Parathyroid Hormone Sales by Type (2018-2029) 9.1.2 Asia Recombinant Human Parathyroid Hormone Revenue by Type (2018-2029) 9.2 Asia Recombinant Human Parathyroid Hormone Market Size by Application 9.2.1 Asia Recombinant Human Parathyroid Hormone Sales by Application (2018-2029) 9.2.2 Asia Recombinant Human Parathyroid Hormone Revenue by Application (2018-2029) 9.3 Asia Recombinant Human Parathyroid Hormone Sales by Region 9.3.1 Asia Recombinant Human Parathyroid Hormone Revenue by Region: 2018 VS 2022 VS 2029 9.3.2 Asia Recombinant Human Parathyroid Hormone Revenue by Region (2018-2029) 9.3.3 Asia Recombinant Human Parathyroid Hormone Sales by Region (2018-2029) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Market Size by Type 10.1.1 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Sales by Type (2018-2029) 10.1.2 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Revenue by Type (2018-2029) 10.2 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Market Size by Application 10.2.1 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Sales by Application (2018-2029) 10.2.2 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Revenue by Application (2018-2029) 10.3 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Sales by Country 10.3.1 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Revenue by Country: 2018 VS 2022 VS 2029 10.3.2 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Revenue by Country (2018-2029) 10.3.3 Middle East, Africa and Latin America Recombinant Human Parathyroid Hormone Sales by Country (2018-2029) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Company Profiles 11.1 NPS Pharma(Shire) 11.1.1 NPS Pharma(Shire) Company Information 11.1.2 NPS Pharma(Shire) Overview 11.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales, Price, Revenue and Gross Margin (2018-2023) 11.1.4 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 NPS Pharma(Shire) Recent Developments 11.2 Takeda 11.2.1 Takeda Company Information 11.2.2 Takeda Overview 11.2.3 Takeda Recombinant Human Parathyroid Hormone Sales, Price, Revenue and Gross Margin (2018-2023) 11.2.4 Takeda Recombinant Human Parathyroid Hormone Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Takeda Recent Developments 11.3 Shandong Buchang Pharmaceuticals 11.3.1 Shandong Buchang Pharmaceuticals Company Information 11.3.2 Shandong Buchang Pharmaceuticals Overview 11.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales, Price, Revenue and Gross Margin (2018-2023) 11.3.4 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Shandong Buchang Pharmaceuticals Recent Developments 11.4 Ascendis Pharma 11.4.1 Ascendis Pharma Company Information 11.4.2 Ascendis Pharma Overview 11.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Sales, Price, Revenue and Gross Margin (2018-2023) 11.4.4 Ascendis Pharma Recombinant Human Parathyroid Hormone Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Ascendis Pharma Recent Developments 11.5 Beijing SL Pharmaceutical 11.5.1 Beijing SL Pharmaceutical Company Information 11.5.2 Beijing SL Pharmaceutical Overview 11.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales, Price, Revenue and Gross Margin (2018-2023) 11.5.4 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Beijing SL Pharmaceutical Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Recombinant Human Parathyroid Hormone Industry Chain Analysis 12.2 Recombinant Human Parathyroid Hormone Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Recombinant Human Parathyroid Hormone Production Mode & Process 12.4 Recombinant Human Parathyroid Hormone Sales and Marketing 12.4.1 Recombinant Human Parathyroid Hormone Sales Channels 12.4.2 Recombinant Human Parathyroid Hormone Distributors 12.5 Recombinant Human Parathyroid Hormone Customers 13 Market Dynamics 13.1 Recombinant Human Parathyroid Hormone Industry Trends 13.2 Recombinant Human Parathyroid Hormone Market Drivers 13.3 Recombinant Human Parathyroid Hormone Market Challenges 13.4 Recombinant Human Parathyroid Hormone Market Restraints 14 Key Findings in The Global Recombinant Human Parathyroid Hormone Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
QYResearch 社の最新刊レポート本レポートと同じKEY WORD(hormone)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/12 10:27 143.85 円 158.71 円 190.22 円 |